NGLFINE logo

NGL FINE CHEM Limited

NGLFINE·NSE·
2,662.10 +12.60 (+0.48%)
Market Cap1656.56 Cr
PE Ratio39.51
Volume8,672
Day High - Low2758.00 - 2619.20
52W High-Low3602.00 - 1271.00
DocStoX Score
4.5/10
Weak
Fair Value
Sign in to see
ROE
13.13%
Average
P/E
39.51x
Expensive
Debt / Equity
0.33
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day2619
2758
52W1271
3602
DocStoX take

Supported by risk (7.9) and momentum (6.4), but held back by valuation (0.8). Risk looks strong at 7.9, but that is offset by valuation at 0.8 and growth at 2.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.5
/10
Weak
Quality
Solid
ROE 13.1%
Valuation
Expensive
P/E 39.5×
Growth
Flat
Revenue +14.2% 5Y CAGR
Risk
Low risk
D/E 0.33
Momentum
Firm
60% of 52-week range

At a glance

Market Cap
₹1,657 Cr
52W High / Low
₹3602 / ₹1271
Dividend Yield
0.06%
Promoter Holding
72.49%
EPS (TTM)
₹67.38
Book Value
₹513.37

Key highlights

  • Profitable in all of the last 5 years
  • Profit shrinking 3% a year
  • Valuation is weak (0.8/10)
1 Positive3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

NGL FINE CHEM LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.